Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Methadone-induced Torsades de pointes.

Russell L, Levine D.

R I Med J (2013). 2013 Jul 30;96(8):20-1.

PMID:
23923121
2.
3.

Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.

K├╝hlkamp V, Mermi J, Mewis C, Seipel L.

J Cardiovasc Pharmacol. 1997 Mar;29(3):373-81.

PMID:
9125676
4.

Methadone-induced torsades de pointes: a twist of fate.

Thanavaro KL, Thanavaro JL.

Heart Lung. 2011 Sep-Oct;40(5):448-53. doi: 10.1016/j.hrtlng.2010.12.008. Epub 2011 Mar 16.

PMID:
21411146
5.

Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes.

Krantz MJ, Garcia JA, Mehler PS.

Pharmacotherapy. 2005 Apr;25(4):611-4.

PMID:
15977920
6.

Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?

Romero J, Baldinger SH, Goodman-Meza D, Engstrom K, Valencia CR, Golive A, Medrano F, Rangasamy S, Makkiya M, Fisher JD, Gross J, Krumerman A, Kim S, Garcia MJ, Di Biase L, Ferrick KJ.

J Interv Card Electrophysiol. 2016 Jan;45(1):37-45. doi: 10.1007/s10840-015-0077-2. Epub 2015 Nov 20.

PMID:
26589717
7.

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.

Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH.

JAMA. 1993 Dec 1;270(21):2590-7.

PMID:
8230644
8.

Cocaine-related torsade de pointes in a methadone maintenance patient.

Krantz MJ, Rowan SB, Mehler PS.

J Addict Dis. 2005;24(1):53-60.

PMID:
15774410
9.

Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.

Nair MK, Patel K, Starer PJ.

Addiction. 2008 Dec;103(12):2062-4. doi: 10.1111/j.1360-0443.2008.02390.x.

PMID:
19469750
10.

Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.

Kao DP, Haigney MC, Mehler PS, Krantz MJ.

Addiction. 2015 Sep;110(9):1468-75. doi: 10.1111/add.13013.

11.

Methadone-induced torsade de pointes in a patient with normal baseline QT interval.

Almehmi A, Malas AM, Yousufuddin M, Rosencrance JG.

W V Med J. 2004 Jul-Aug;100(4):147-8.

PMID:
15471174
12.

Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?

Mayet S, Gossop M, Lintzeris N, Markides V, Strang J.

Drug Alcohol Rev. 2011 Jul;30(4):388-96. doi: 10.1111/j.1465-3362.2010.00237.x. Epub 2010 Sep 6.

PMID:
21355918
13.

Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes.

Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS.

Pharmacotherapy. 2003 Jun;23(6):802-5.

PMID:
12820821
14.

Treatment of methadone-induced torsades de pointes with lidocaine.

Rajpal S, Mundi AS, Reddy PC, Akkus NI.

J La State Med Soc. 2013 Nov-Dec;165(6):338-41.

PMID:
25073261
15.

Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes.

Esses JL, Rosman J, Do LT, Schweitzer P, Hanon S.

J Interv Card Electrophysiol. 2008 Nov;23(2):117-9. doi: 10.1007/s10840-008-9280-8. Epub 2008 Aug 7.

PMID:
18686025
16.

QTc prolongation and torsades de pointes associated with methadone therapy.

Routhier DD, Katz KD, Brooks DE.

J Emerg Med. 2007 Apr;32(3):275-8. Epub 2007 Feb 2.

PMID:
17394991
17.

Chronic methadone therapy complicated by torsades de pointes: a case report.

Pimentel L, Mayo D.

J Emerg Med. 2008 Apr;34(3):287-90. Epub 2007 Nov 26.

PMID:
18022786
18.

Methadone induced Torsades de Pointes mimicking seizures in clinical presentation.

Raina S, Paydak H, Al-Lahham T, Shihabuddin BS.

Am J Drug Alcohol Abuse. 2014 Nov;40(6):490-2. doi: 10.3109/00952990.2014.965311. Epub 2014 Oct 16. No abstract available.

PMID:
25321151
19.

Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.

Couderc JP, Kaab S, Hinterseer M, McNitt S, Xia X, Fossa A, Beckmann BM, Polonsky S, Zareba W.

J Clin Pharmacol. 2009 Jan;49(1):6-16. doi: 10.1177/0091270008325927. Epub 2008 Oct 28.

PMID:
18957528
20.

Methadone-associated Q-T interval prolongation and torsades de pointes.

Stringer J, Welsh C, Tommasello A.

Am J Health Syst Pharm. 2009 May 1;66(9):825-33. doi: 10.2146/ajhp070392. Review. Erratum in: Am J Health Syst Pharm. 2010 Jan 15;67(2):94.

PMID:
19386945

Supplemental Content

Support Center